Showing Results for
- Academic Journals (384)
Search Results
- 384
Academic Journals
- 384
- Search Terms:
- 1From: Addiction Science & Clinical Practice. (Vol. 14, Issue 1) Peer-ReviewedBackground In Dar es Salaam Tanzania, the first opioid treatment program (OTP) in Sub-Saharan Africa, had very high rates of enrollment of people who use drugs (PWUD) but low rates of antiretroviral therapy (ART)...
- 2From: Addiction Science & Clinical Practice. (Vol. 14, Issue 1) Peer-Reviewed
"They didn't give up on me": a women's transitions clinic from the perspective of re-entering women.
Background Women recently released from incarceration have increased rates of co-occurring substance use, physical health, and mental health disorders. During re-entry, they face challenges navigating needed health... - 3From: Addiction Science & Clinical Practice. (Vol. 15, Issue 1) Peer-ReviewedBackground If Russia is to achieve the UNAIDS 90-90-90 HIV targets, better approaches to engage, effectively treat, and retain patients in care are needed. This paper describes the protocol of a randomized controlled...
- 4From: Addiction Science & Clinical Practice. (Vol. 15, Issue 1) Peer-ReviewedIn response to the findings of the Lynch et al. study on the association of suicide mortality and substance use disorder, this commentary addresses the need for increased suicide assessment and screening for patients who...
- 5From: Addiction Science & Clinical Practice. (Vol. 16, Issue 1) Peer-ReviewedOpioid use disorder (OUD) is a medical condition that has evolved into a serious and deadly epidemic in the United States. Both medical and psychological interventions are called for to end this growing epidemic, but too...
- 6From: Addiction Science & Clinical Practice. (Vol. 16, Issue 1) Peer-ReviewedBackground Opioid withdrawal symptoms prior to buprenorphine initiation may be intolerable and as a result, alternative strategies have emerged. We aim to systematically review the efficacy and safety of buprenorphine...
- 7From: Addiction Science & Clinical Practice. (Vol. 16, Issue 1) Peer-ReviewedBackground The emergency department (ED) offers an important opportunity to identify patients with opioid use disorder (OUD) and initiate treatment. However, post-ED follow-up is challenging, and novel approaches to...
- 8From: Addiction Science & Clinical Practice. (Vol. 17, Issue 1) Peer-ReviewedBackground Medication treatment for opioid use disorder (OUD) (MOUD; buprenorphine and methadone) reduces opioid use and overdose. Discontinuation of MOUD can quickly lead to relapse, overdose and death. Few persons...
- 9From: Addiction Science & Clinical Practice. (Vol. 17, Issue 1) Peer-ReviewedBackground Until recently, few carceral facilities offered medications for opioid use disorder (MOUD). Although more facilities are adopting MOUD, much remains to be learned about addressing implementation challenges...
- 10From: Addiction Science & Clinical Practice. (Vol. 17, Issue 1) Peer-ReviewedBackground The opioid antagonist extended-release naltrexone (XR-NTX) in the treatment of opioid use disorder (OUD) is effective in terms of safety, abstinence from opioid use and retention in treatment. However, it is...
- 11From: Addiction Science & Clinical Practice. (Vol. 17, Issue 1) Peer-ReviewedBackground Post-traumatic stress disorder (PTSD) and substance use disorders (SUDs) often co-occur in adolescent patients. Previous research has shown that these patients differ from SUD patients without PTSD in terms...
- 12From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground Co-use of stimulants and opioids is rapidly increasing. Randomized clinical trials (RCTs) have established the efficacy of medications for opioid use disorder (MOUD), but stimulant use may decrease the...
- 13From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground Although the detrimental health effects of alcohol are well established, consumption levels are high in many high-income countries such as Germany. Improving alcohol health literacy presents an integrated...
- 14From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground Individuals who have substance use disorders may have an elevated risk of suicidality. This study sought to examine the prevalence of, and identify factors associated with, suicidality in adults with opioid...
- 15From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground In studies of the general population and of military veterans, many primary care patients with hazardous drinking and PTSD and/or depression (abbreviated here as HD +) do not initiate or engage with...
- 16From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground Tent encampments in the neighborhood surrounding Boston Medical Center (BMC) grew to include 336 individuals at points between 2019 and 21, prompting public health concerns. BMC, the City of Boston, and...
- 17From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground During the COVID-19 pandemic, federal regulations in the USA for methadone treatment of opioid use disorder (OUD) were temporarily revised to reduce clinic crowding and promote access to treatment. Methods...
- 18From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground Oral antiretroviral therapy (ART) has been effective at reducing mortality rates of people with HIV. However, despite its effectiveness, people who use drugs face barriers to maintaining ART adherence....
- 19From: Addiction Science & Clinical Practice. (Vol. 18, Issue 1) Peer-ReviewedBackground The harms of opioid use disorder (OUD) and HIV infection disproportionately impact marginalized populations, especially people experiencing homelessness and people who inject drugs (PWID). Mobile OUD service...
- 20From: Addiction Science & Clinical Practice. (Vol. 13, Issue 1) Peer-ReviewedAuthor(s): P. Todd Korthuis1 and E. Jennifer Edelman2 The HIV care continuum identifies five stages of HIV medical care: (1) HIV diagnosis, (2) linkage to HIV care, (3) engagement and retention in HIV care, (4)...